A couple of years before he was convicted of securities fraud, Martin Shkreli was the chief executive of a pharmaceutical company that acquired the rights to Daraprim, a lifesaving antiparasitic drug. Previously the drug cost $13.
https://www.nytimes.com/interactive/2019/08/14/magazine/slavery-capitalism.html